LIXTE BIOTECHNOLOGY HOLDINGS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Cash And Cash Equivalents At Carrying Value of $4.20 million for the year ending 2023.

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed a decrease of -21.5% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2024.
  • XBRL data for this metric is available from 2012 to 2023 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $115.4 thousand | Q2 2014: $46.7 thousand | Q3 2014: $8.9 thousand | Q1 2015: $140.1 thousand | Q2 2015: $126.5 thousand | Q3 2015: $217.6 thousand | Q1 2016: $99.4 thousand | Q2 2016: $95.8 thousand | Q3 2016: $669.8 thousand | Q1 2017: $870.9 thousand | Q2 2017: $2.03 million | Q3 2017: $1.59 million | Q4 2017: $1.31 million | Q1 2018: $808.0 thousand | Q2 2018: $536.0 thousand | Q3 2018: $374.4 thousand | Q1 2019: $3.89 million | Q2 2019: $3.56 million | Q3 2019: $2.98 million | Q1 2020: $2.18 million | Q2 2020: $1.77 million | Q3 2020: $1.08 million | Q1 2021: $7.74 million | Q2 2021: $6.80 million | Q3 2021: $5.96 million | Q1 2022: $3.78 million | Q2 2022: $7.74 million | Q3 2022: $6.56 million | Q1 2023: $4.09 million | Q2 2023: $2.91 million | Q3 2023: $5.11 million | Q4 2023: $4.20 million | Q1 2024: $3.41 million.
  • Over the full 12 years of available data (2012 to 2023), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 154.0%.
  • Historical annual values: Fiscal year 2023: $4.20 million | Fiscal year 2022: $5.35 million | Fiscal year 2021: $4.82 million | Fiscal year 2020: $5.07 million | Fiscal year 2019: $2.60 million | Fiscal year 2018: $4.27 million | Fiscal year 2017: $1.31 million | Fiscal year 2016: $199.9 thousand | Fiscal year 2015: $25.3 thousand | Fiscal year 2014: $44.4 thousand | Fiscal year 2013: $475.0 thousand | Fiscal year 2012: $1.66 million.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: